The objective of the study is to determine the structure of the current pharmaceutical market, the conditions by which the demand for pharmaceutical products is determined, to assess the corporate structure from a territorial perspective, to analyze the overall level of renationalization in the industry, to review global mergers and acquisitions in the pharmaceutical market, and to provide a typology of the various companies in the global pharmaceutical industry and a review of the territorial distribution of their assets.
It is essential to note that the survey is based on a comparative analysis of trends in the restructuring of global value chains in pharmaceuticals, digitalization of the pharmaceutical industry and healthcare, as well as a quantitative analysis of revenue and value added indicators of the world’s largest pharmaceutical multinational companies.
Nowadays, it is significant to realize that the global pharmaceutical market is a rather efficient and evolving model. The point here is that due to the various conditions of factors that affect the social life of the population today, the dynamic system, as well as corporations, also react to market challenges. A prime example is the coronavirus pandemic, where it was necessary to respond in a short time to a problem that affected the whole world. Pharmaceuticals had to work quickly and swiftly to prevent a multitude of deaths around the world, which is only worth the creation of a vaccine that helped a multitude of people. Similarly, it is necessary to analyze the actions of pharmaceutical companies, which in a fairly short period of time were able to redistribute capital in the industry in question, shifts in the international division of labor and in the allocation of production assets.
To be noted that the major technological and conceptual trends that will drive the global pharmaceutical market include:
1. Precision medicine or personalized medicine. This is a new concept in healthcare that deals with the selection of drug therapy according to individual patient characteristics such as genetic traits, lifestyle, and environment. This healthcare model is evolving towards a P4 approach: prediction, personalization, prevention and patient and societal involvement in the process of health care monitoring.